Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA

By sjmartinez • July 28, 2023

Sinari S, Koska J, Hu Y, Furtado J, Jensen MK, Budoff MJ, Nedelkov D, McClelland RL, Billheimer D, Reaven P. Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA. Arterioscler Thromb Vasc Biol. 2023 Aug;43(8):1560-1571. doi: 10.1161/ATVBAHA.123.319035. Epub 2023 Jun 15. PMID: 37317850.

Tags: apolipoprotein, Cardiology/Epi, cardiovascular disease, Harbor UCLA, lipids, Publications, risk

3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States

Eleid MF, Krishnaswamy A, Kapadia S, Yadav P, Rajagopal V, Makkar R, Stinis C, Chetcuti S, Morse A, Frisoli T, Frangieh AH, Abbas AE, Whisenant[...]

The Association of Arsenic Exposure and Metabolism Biomarkers with Subclinical Measures of Liver Disease: a cross-sectional investigation in the Multi-Ethnic Study of Atherosclerosis

Wu HC, Glabonjat RA, Schilling K, Anderson WA, Gao S, Relloso AD, LoIacono N, Slowly M, Nigra AE, Sanchez T, Sobel MH, Galvez-Fernandez M, Budoff[...]

Clinical and socioeconomic factors associated with recurrent atrial fibrillation after catheter ablation or antiarrhythmic drug therapy

An J, Bansal N, Zheng C, Lee MS, Wei R, Harrison TN, Fan D, Garcia E, Lidgard B, Zelnick LR, Singer DE, Go AS. Clinical[...]